Raymond James & Associates Edwards Lifesciences Corp Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Raymond James & Associates holds 1,675,733 shares of EW stock, worth $114 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

1,675,733

Previous 1,825,230 8.19%

Holding current value

$114 Million

Previous $169 Million 34.41%

% of portfolio

0.07%

Previous 0.11%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$59.7 - $93.78 $8.92 Million - $14 Million	-149,497 Reduced 8.19%	1,675,733 $111 Million
Q2 2024 Jul 19, 2024	BUY	$84.3 - $94.31 $4.23 Million - $4.73 Million	50,124 Added 2.82%	1,825,230 $169 Million
Q1 2024 Apr 22, 2024	BUY	$72.54 - $95.56 $10.1 Million - $13.3 Million	139,515 Added 8.53%	1,775,106 $170 Million
Q4 2023 Jan 16, 2024	SELL	$61.71 - $77.76 $1.42 Million - $1.79 Million	-23,062 Reduced 1.39%	1,635,591 $125 Million
Q3 2023 Oct 24, 2023	BUY	$69.28 - $93.38 $4.36 Million - $5.88 Million	62,938 Added 3.94%	1,658,653 $115 Million
Q2 2023 Jul 25, 2023	BUY	$81.41 - $94.33 $10.5 Million - $12.1 Million	128,746 Added 8.78%	1,595,715 $151 Million
Q1 2023 Apr 14, 2023	BUY	$74.26 - $84.51 $1.28 Million - $1.46 Million	17,296 Added 1.19%	1,466,969 $121 Million
Q4 2022 Feb 08, 2023	SELL	$68.3 - $87.44 $10.5 Million - $13.4 Million	-153,510 Reduced 9.58%	1,449,673 $108 Million
Q3 2022 Oct 25, 2022	SELL	$82.37 - $107.29 $4.36 Million - $5.67 Million	-52,880 Reduced 3.19%	1,603,183 $132 Million
Q2 2022 Aug 12, 2022	BUY	$86.5 - $128.27 $807,996 - $1.2 Million	9,341 Added 0.57%	1,656,063 $157 Million
Q1 2022 May 11, 2022	BUY	$101.96 - $128.34 $3.71 Million - $4.66 Million	36,348 Added 2.26%	1,646,722 $194 Million
Q4 2021 Feb 08, 2022	BUY	$106.37 - $130.68 $14.9 Million - $18.3 Million	139,703 Added 9.5%	1,610,374 $209 Million
Q3 2021 Nov 02, 2021	BUY	$102.91 - $122.75 $4.36 Million - $5.21 Million	42,404 Added 2.97%	1,470,671 $166 Million
Q2 2021 Aug 11, 2021	BUY	$83.84 - $104.76 $26.7 Million - $33.4 Million	318,774 Added 28.73%	1,428,267 $148 Million
Q1 2021 May 14, 2021	BUY	$78.68 - $90.67 $4.29 Million - $4.94 Million	54,498 Added 5.17%	1,109,493 $92.8 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $13 Million - $16.5 Million	181,235 Added 20.74%	1,054,995 $96.2 Million
Q3 2020 Nov 04, 2020	BUY	$67.19 - $87.44 $34.5 Million - $44.9 Million	513,952 Added 142.84%	873,760 $69.7 Million
Q2 2020 Jul 28, 2020	BUY	$57.54 - $76.95 $14.1 Million - $18.9 Million	245,084 Added 213.63%	359,808 $24.9 Million
Q1 2020 Apr 21, 2020	SELL	$52.41 - $81.0 $2.04 Million - $3.15 Million	-38,839 Reduced 25.29%	114,724 $21.6 Million
Q4 2019 Feb 12, 2020	BUY	$71.7 - $82.09 $44,238 - $50,649	617 Added 0.4%	153,563 $35.8 Million
Q3 2019 Nov 07, 2019	BUY	$61.55 - $75.43 $1.19 Million - $1.45 Million	19,277 Added 14.42%	152,946 $33.6 Million
Q2 2019 Aug 06, 2019	BUY	$55.74 - $64.41 $144,255 - $166,693	2,588 Added 1.97%	133,669 $24.7 Million
Q1 2019 May 06, 2019	SELL	$47.89 - $64.05 $533,159 - $713,068	-11,133 Reduced 7.83%	131,081 $25.1 Million
Q4 2018 Feb 11, 2019	BUY	$46.41 - $56.94 $81,820 - $100,385	1,763 Added 1.26%	142,214 $21.8 Million
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $183,257 - $232,700	4,010 Added 2.94%	140,451 $24.5 Million
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $610,685 - $738,001	-14,386 Reduced 9.54%	136,441 $19.9 Million
Q1 2018 May 14, 2018	SELL	$37.19 - $47.45 $453,420 - $578,510	-12,192 Reduced 7.48%	150,827 $21 Million
Q4 2017 Feb 14, 2018	SELL	$33.79 - $39.39 $47,542 - $55,421	-1,407 Reduced 0.86%	163,019 $18.4 Million
Q3 2017 Nov 13, 2017	BUY	$36.29 - $38.83 $85,100 - $91,056	2,345 Added 1.45%	164,426 $18 Million
Q2 2017 Aug 14, 2017	BUY	N/A	162,081	162,081 $19.2 Million

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Edwards Lifesciences Corp Transaction History